Linda Moloney is a Senior Health Policy Consultant at Technopolis Group, Paris, with over 10 years of international experience in EU institutions and national regulatory agencies.

She has expertise in pharmacovigilance, regulatory science, risk assessment, and EU governance frameworks, and has contributed to health policy and medicines safety across multiple countries. She has worked at two national regulatory agencies for medicines and health products in Europe, coordinating pharmacovigilance signals and structured risk analyses as well as monitoring vaccine safety and conducting signal detection; and at the EDQM (Council of Europe) implementing its Safety Management System and revising hazard classification policies. Earlier, she contributed to public health initiatives on new psychoactive substance at an EU level at EMCDDA, and on food safety at a global level at WHO. Linda’s career began as a community pharmacist in Ireland. Linda holds a Master’s Degree in International Health Care Management, Economics and Policy (Bocconi University), a Diploma in Pharmacoepidemiology and Pharmacovigilance (University of Bordeaux), and a BSc in Pharmacy (Trinity College Dublin).